Suppr超能文献

[血友病性关节炎患者关节置换术后止血与抗栓平衡的临床经验]

[Clinical experience on postoperative balance of hemostasis and antithrombus for patients with hemophilic arthritis after arthroplasty].

作者信息

Pan Jia-Fei, Chu Xiao-Bing, Zhuang Ru-Jie, Zhou Li, Jin Hong-Ting, Wu Cheng-Liang, Xiao Lu-Wei, Tong Pei-Jian

出版信息

Zhongguo Gu Shang. 2015 Mar;28(3):268-71.

Abstract

OBJECTIVE

To observe the clinical significance of postoperative personalized antithrombotic therapy for patients with hemophilic arthritis (HA) patients after arthroplasty.

METHODS

From September 2005 to October 2013, 11 cases of arthroplasty for hemophilic arthritis in hip and knee total operation 14 times,including 1 case of double knees (calculated as one operation), operation in left knees 6 times, operation in right knees 5 times, 2 in hip. All the patients were male and the age ranged from 23 to 57 years old,with an average of (36.1 ± 11.0) years old; the average weight was (64.1 ± 8.9) kg. All the patients were preoperatively diagnosed and classified as hemophilic arthritis with the radiological images and laboratory tests. According to the function of joints, the risk of postoperative venous thromboembolism (VTE), and dynamic observation of Factor VIII:C (FVIII:C) activity, patients were treated with personalized antithrombus by adjusting the dosage of recombinant human coagulation factor VIII (Kogenate FS). All the patients were orderly divided into postoperatively distal joints moving group and none-moving group to observe the coagulation function.

RESULTS

The enrolled patients had no postoperative complication of VTE and pulmonary embolism (PE). The APTT and D-2 were different between two groups in the postoperative early stage. Length of hospital day was shorter in the moving group than none-moving group.

CONCLUSION

Because of the self-coagulation disorder, patients with HA tended to bleed. However it doesn't mean that there is no risk of postoperative thrombosis. Therefore,it's important to determine how to control the balance between postoperative antithrombus, hemostasis,and coagulation factor replacement therapy after arthroplasty for HA. Postoperative moving has proved helpful for HA, especially in reducing the risk of hemostasis and shortening the time in hospital.

摘要

目的

观察血友病性关节炎(HA)患者关节置换术后个性化抗栓治疗的临床意义。

方法

选取2005年9月至2013年10月因血友病性关节炎行髋、膝关节置换手术14例次的患者11例,其中双膝置换1例(计为1次手术),左膝置换6例次,右膝置换5例次,髋关节置换2例次。所有患者均为男性,年龄23~57岁,平均(36.1±11.0)岁;平均体重(64.1±8.9)kg。所有患者术前均经影像学及实验室检查确诊为血友病性关节炎。根据关节功能、术后静脉血栓栓塞症(VTE)风险及动态观察凝血因子Ⅷ:C(FVIII:C)活性,通过调整重组人凝血因子Ⅷ(科跃奇)剂量对患者进行个性化抗栓治疗。将所有患者有序分为术后远端关节活动组和非活动组,观察凝血功能。

结果

入选患者术后均未发生VTE及肺栓塞(PE)并发症。术后早期两组活化部分凝血活酶时间(APTT)及D-二聚体(D-2)不同。活动组住院时间短于非活动组。

结论

HA患者因自身凝血障碍易出血,但并不意味着术后无血栓形成风险。因此,确定如何在HA患者关节置换术后抗栓、止血及凝血因子替代治疗之间控制平衡很重要。术后活动已证明对HA患者有益,尤其有助于降低止血风险及缩短住院时间。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验